Today: 21 May 2026
CrowdStrike stock slips late in session despite Gartner “Customers’ Choice” nod — what CRWD investors watch next
28 January 2026
1 min read

CrowdStrike stock slips late in session despite Gartner “Customers’ Choice” nod — what CRWD investors watch next

New York, January 28, 2026, 3:52 PM EST — Regular session

CrowdStrike Holdings Inc (CRWD) shares slipped about 1% on Wednesday, retreating late despite fresh recognition from Gartner. The stock dropped $4.62, closing at $472.04, after trading between $471.36 and $486.87 earlier in the session.

Markets slipped as investors remained cautious after the Federal Reserve opted to keep rates unchanged, with key tech earnings coming after the close. Brian Jacobsen, chief economic strategist at Annex Wealth Management, said, “The real action will be in the press conference.” Reuters

Analysts are still treading carefully. On Tuesday, Steve Koenig at Macquarie stuck with a Neutral rating on CrowdStrike, maintaining his $485 price target, according to . Another report pointed to valuation concerns as the key factor behind the cautious stance.

On Wednesday, CrowdStrike announced it had earned the “Customers’ Choice” badge in Gartner Peer Insights’ 2026 Voice of the Customer report for endpoint protection platforms — software that blocks attacks on laptops, servers, and other devices. “The strongest validation in cybersecurity comes from customers,” said Elia Zaitsev, CrowdStrike’s chief technology officer. Gartner Peer Insights emphasizes that this award reflects user reviews and adoption data, not a vendor endorsement. CrowdStrike

Cybersecurity shares were all over the place: Palo Alto Networks gained slightly, Zscaler dropped more than 2%, Fortinet edged up, and SentinelOne remained flat.

CrowdStrike closed Tuesday up 1.78% at $476.66, with volume beating its 50-day average, MarketWatch reports. The stock remains about 16% shy of its November 52-week high of $566.90.

Shares continue to face legal and reputational hurdles after the July 2024 outage triggered by a faulty update. While a U.S. judge recently dismissed a shareholder lawsuit, Reuters reported that other cases remain active, including one filed by Delta Air Lines.

CrowdStrike’s next earnings report is expected around March 3, based on Nasdaq’s projections. However, the date might shift ahead of any formal confirmation.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Bank of America stock slips after Fed holds rates: what traders watch next for BAC
Previous Story

Bank of America stock slips after Fed holds rates: what traders watch next for BAC

NextEra Energy stock price today: NEE steadies near a 52-week high as investors parse earnings, data-center demand
Next Story

NextEra Energy stock price today: NEE steadies near a 52-week high as investors parse earnings, data-center demand

Go toTop